在AJCC不同阶段的胰腺癌中辅助化疗:倾向性得分匹配分析

Xiao-Hui Li1, En-Liang Zhou1, Xiao-Yuan Dong2

  • 1Department of Pancreatobiliary Surgery, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, 651 Dongfengdong Road, Guangzhou, 510060, China.

PubMed
概括

辅助化疗改善了第一阶段和第二阶段可切除胰腺癌患者的生存率. 然而,它在第三阶段表现出有限的疗效,突出显示了对晚期胰腺癌的新治疗方法的需求.